Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
Working Life
Pfizer's pursuit of happiness
The pharma giant is rated number one for 'career bliss' in the US and it's trying to create the same buzz down under. Karen Keast spoke to MD David Gallagher.
Approvals Action
Companies boost nicotine and haemophilia ranges
Baxter adds to haemophilia A portfolio while Medis Pharma registers six new brands of nicotine replacement therapy.
Pipeline Monitor
More indications for first-in-class cancer drug
BMS says it will file Opdivo for melanoma with the FDA adding the deadly skin cancer to a previous filing for NSCLC with more indications likely to come.
Open Forum
Digital - how to get it right
After years of working in pharma, Mark Razzell says the industry is yet to get digital right but believes there's hope for success through applying closed loop marketing principles to common research and promotional activities.